Cargando…
Role of olmesartan in combination therapy in blood pressure control and vascular function
Angiotensin receptor blockers have emerged as a first-line therapy in the management of hypertension and hypertension-related comorbidities. Since national and international guidelines have stressed the need to control blood pressure to <140/90 mmHg in uncomplicated hypertension and <130/80 mm...
Autores principales: | Ferrario, Carlos M, Smith, Ronald D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941783/ https://www.ncbi.nlm.nih.gov/pubmed/20859541 |
Ejemplares similares
-
Effect of angiotensin receptor blockade on endothelial function: focus on olmesartan medoxomil
por: Ferrario, Carlos
Publicado: (2009) -
Impact of olmesartan on blood pressure, endothelial function, and cardiovascular outcomes
por: Pimenta, Eduardo, et al.
Publicado: (2010) -
Safety and tolerability of fixed antihypertensive combinations in blood pressure control: focus on olmesartan medoxomil and amlodipine combination
por: Uddin, Ijlal, et al.
Publicado: (2010) -
Single-Pill Combination with Three Antihypertensive Agents to Improve Blood Pressure Control in Hypertension: Focus on Olmesartan-Based Combinations
por: Burnier, Michel, et al.
Publicado: (2023) -
Critical appraisal of amlodipine and olmesartan medoxomil fixed-dose combination in achieving blood pressure goals
por: Basile, Jan
Publicado: (2010)